Abiopharma

Management and officers – staffing as of 18.6.26

Grifols Communications - Resolutions approved by the General Meeting of Shareholders

Clinical trial NCT04335682 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-01 → 2026-05-01

Clinical trial NCT07486869 updates: 1. start date: 2026-05-01 → 2026-07-01 2. collaborators added: Swedish Orphan Biovitrum 3. collaborators removed: Swedish Orphan Biovitrum AB

Clinical trial NCT07431398 updates: 1. status: RECRUITING → TERMINATED 2. primary completion date: 2026-05-31 → 2026-06-01 3. enrollment: 24 → 13 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05171816: completion date: 2026-04-28 → 2027-02-05.

Clinical trial NCT03294083 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. start date: 2018-06-07 → 2018-06-19 3. completion date: 2023-11-01 → 2023-02-16 4. primary completion date: 2023-08-01 → 2023-02-16 5. enrollment: 89 → 95 participants

Clinical trial NCT05071937 updates: 1. completion date: 2033-03-01 → 2034-12-31 2. primary completion date: 2031-12-31 → 2033-11-30

Clinical trial NCT07428369 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 1570 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07144826 updates: 1. start date: 2026-03-09 → 2026-03-06 2. collaborators added: United States Department of Defense